Table 1 Patient characteristics of 90 AML cases from TCGA-LAML for survival analyses

Age (range)

48.5 (21–65)

Sex, n

 Male

49 (54.4%)

 Female

41 (45.6%)

FAB classification, n

 M0

8 (8.9%)

 M1

27 (30.0%)

 M2

25 (27.8%)

 M4

19 (21.1%)

 M5

10 (11.1%)

 M6

1 (1.1%)

Cytogenetic abnormality, n

 Normal karyotype

43 (47.8%)

 RUNX1::RUNX1T1

6 (6.7%)

 CBFB::MYH11

8 (8.9%)

 MLL translocation, t(9;11)

1 (1.1%)

 Other intermediate risk cytogenetic abnormality

9 (10.0%)

 MLL translocation, otherwise

4 (4.4%)

 BCR::ABL1

2 (2.2%)

 Other poor risk cytogenetic abnormality

7 (7.8%)

 Complex cytogenetics

8 (8.9%)

 Data not available

2 (2.2%)

NCCN2017 risk stratification, n

 Good

14 (15.6%)

 Intermediate

49 (54.4%)

 Poor

25 (27.8%)

 Data not available

2 (2.2%)

Upfront allo-HCT, n

 Performed

33 (36.7%)

 Not performed

57 (63.3%)

Total n = 90